GCase protein levels and activity are considerably lower in the substantia nigra of the PD post-mortem brain even without the GBA1 mutations [22–24], and the accumulation of α-synuclein leads to a substantial reduction of GCase levels and activity [19, 22]. The gene discussed is GBA1; the disease is Parkinson disease.